Zobrazeno 1 - 10
of 12
pro vyhledávání: ''
Autor:
Burcu Çakar, Murat Karateke, Basak Doganavsargil, Elvina Almuradova, Bulent Karabulut, Murat Sezak, Mustafa Harman, Pınar Gürsoy
Panitumumab and cetuximab are monoclonal antibodies known to be effective in metastatic colorectal cancer (mCRC). Although the survival benefits when combined with chemotherapy have been determined, there are no studies comparing the two agents with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a06cfd81762841b60111d39526c20789
https://hdl.handle.net/11454/70095
https://hdl.handle.net/11454/70095
Measurements are one of the most important means of evaluating the quality of antibiotic consumption. This study has evaluated the antibiotic consumption using one-day point prevalence study data collected from different hospitals in Turkey. This res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2da57163e4e82171c7a581fe29f1ddab
https://hdl.handle.net/20.500.12684/10848
https://hdl.handle.net/20.500.12684/10848
Publikováno v:
Hematology, 22(9), 544-547. Taylor & Francis Ltd
Systemic mastocytosis (SM) is a myeloproliferative disease characterized by the accumulation of aberrant mast cells. Since advanced subtypes of SM can lead to organ dysfunction and shortened survival, timely recognition of progressive disease is impo
Autor:
Esra Akyuz, Omer Kitis, Ahmet Acarer, Cenk Eraslan, Mehmet Cem Çallı, Serkan Guneyli, Zafer Colakoglu, Elçin Aydın
WOS: 000459561000002
PubMed: 30373485
Objectives: To evaluate the magnetic resonance imaging (MRI)-derived parameters in differentiation of patients with progressive supranuclear palsy (PSP) from patients with Parkinson's disease (PD), mult
PubMed: 30373485
Objectives: To evaluate the magnetic resonance imaging (MRI)-derived parameters in differentiation of patients with progressive supranuclear palsy (PSP) from patients with Parkinson's disease (PD), mult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c30669438b6c595d0e0d7d4b793d53b6
https://hdl.handle.net/20.500.12628/2964
https://hdl.handle.net/20.500.12628/2964
demirdal, tuna/0000-0002-9046-5666 WOS: 000495832300001 PubMed: 31713451 Background: To investigate the role of soluble urokinase plasminogen activator receptor (suPAR) in the diagnosis of diabetic foot infection and to determine whether it is superi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47d187dd315fd1c3c66da19da0149015
https://hdl.handle.net/20.500.12697/4299
https://hdl.handle.net/20.500.12697/4299
Autor:
José Luis Górriz, Jose M. Valdivielso, Elvira Fernández, Núria Alonso, Teresa Bretones, David Arroyo, Didac Mauricio, Núria Amigó, Milica Bozic, Carles Forné, Marcelino Bermúdez-López, María Dolores del Pino y Pino, Serafí Cambray
Publikováno v:
EXPERT OPINION ON THERAPEUTIC TARGETS
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Expert Opinion on Therapeutic Targets
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Expert Opinion on Therapeutic Targets
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Background: Chronic kidney disease (CKD) is an independent risk factor for atherosclerotic disease. We hypothesized that CKD promotes a proatherogenic lipid profile modifying lipoprotein composition and particle number. Methods: Cross-sectional study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46035e99aa6bb2330edec22b0b5dd124
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2668
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2668
Autor:
Mehmet Tetikoğlu, Fatih Özcura, Hacı Murat Sağdık, Medine Aslı Yıldırım, Muhammed Mustafa Kurt, Serdar Aktas
WOS: 000427835700013
PubMed: 28697703
Background: To evaluate the effects of intravitreal aflibercept (IVA) on retinal vessel diameters in patients with neovascular age-related macular degeneration (AMD).Design, setting, and participants: A
PubMed: 28697703
Background: To evaluate the effects of intravitreal aflibercept (IVA) on retinal vessel diameters in patients with neovascular age-related macular degeneration (AMD).Design, setting, and participants: A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bf20ba8dc115a7988d974fd9962837a
https://hdl.handle.net/20.500.12438/3841
https://hdl.handle.net/20.500.12438/3841
Autor:
Akif Selim Yavuz, Ugur Ozbek, Mustafa Pehlivan, Güray Saydam, Mehmet Sönmez, Rıdvan Ali, Leylagül Kaynar, Zafer Baslar, Demet Aydin, Osman Ilhan, Simten Dagdas, Ibrahim C. Haznedaroglu, Olga Meltem Akay, Birol Guvenc, Orhan Ayyildiz, Ilkiz M. Dag, Bülent Ündar, Gulnur Akin
WOS: 000448137100007
PubMed ID: 29486663
Objectives: This report presents final results (24 months of follow-up) from the first prospective, national study of frontline nilotinib in chronic myeloid leukemia (CML) patients in Turkey. Methods
PubMed ID: 29486663
Objectives: This report presents final results (24 months of follow-up) from the first prospective, national study of frontline nilotinib in chronic myeloid leukemia (CML) patients in Turkey. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e810501d0345605c9c590da656ad01e2
https://hdl.handle.net/20.500.12605/9241
https://hdl.handle.net/20.500.12605/9241
Autor:
Marta Pratcorona, Susana G. Kalko, Bernat Gel, Marina Díaz-Beyá, Alfons Navarro, Mireia Camós, Josep F. Nomdedeu, Jorge Sierra, Jordi Esteve, Salut Brunet, Montserrat Torrebadell
Publikováno v:
LEUKEMIA & LYMPHOMA
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
In intermediate-risk cytogenetic acute myeloid leukemia (IRC-AML) patients, novel biomarkers to guide post-remission therapy are needed. We analyzed with high-density arrays 40 IRC-AML patients who received a non-allogeneic hematopoietic stem-cell tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea34ca4a81d425808e291bbf1e2a7418
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=13541
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=13541
Autor:
Salvador F. Aliño, Virginia Bosó, Juan Eduardo Megías-Vericat, Blanca Boluda, José Cervera, Rebeca Rodríguez-Veiga, Luis Rojas, José Luis Poveda, Luis Sendra, María José Herrero, Federico Moscardó, Pau Montesinos, David Martínez-Cuadrón, Miguel A. Sanz
Publikováno v:
Leukemia & lymphoma
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Cytarabine is considered the most effective chemotherapeutic option in acute myeloid leukemia (AML). The impact of 10 polymorphisms in cytarabine metabolic pathway genes were evaluated in 225 adult de novo AML patients. Variant alleles of DCK rs23067
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f7654ffb17eed251c5f5710dcb24e23
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=7164
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=7164